Hamilton Lane Advisors’s Precision BioSciences DTIL Stock Holding History

Hamilton Lane Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,637	Closed	-$28.9K	–	20
2023 Q4	$28.9K	Hold	2,637	–	–	0.01%	26
2023 Q3	$27K	Hold	2,637	–	–	0.02%	31
2023 Q2	$41.6K	Hold	2,637	–	–	0.02%	52
2023 Q1	$59.6K	Hold	2,637	–	–	0.02%	58
2022 Q4	$94K	Hold	2,637	–	–	0.03%	63
2022 Q3	$103K	Hold	2,637	–	–	0.04%	63
2022 Q2	$127K	Hold	2,637	–	–	0.05%	65
2022 Q1	$244K	Hold	2,637	–	–	0.05%	67
2021 Q4	$585K	Hold	2,637	–	–	0.08%	65
2021 Q3	$913K	Hold	2,637	–	–	0.15%	54
2021 Q2	$990K	Hold	2,637	–	–	0.31%	51
2021 Q1	$819K	Hold	2,637	–	–	0.27%	50
2020 Q4	$660K	Hold	2,637	–	–	0.25%	40
2020 Q3	$487K	Hold	2,637	–	–	0.24%	37
2020 Q2	$659K	Hold	2,637	–	–	0.35%	27
2020 Q1	$477K	Hold	2,637	–	–	0.28%	33
2019 Q4	$1.1M	Sell	2,637 -6,500	-71%	-$2.04M	0.48%	30
2019 Q3	$2.3M	Hold	9,137	–	–	0.96%	17
2019 Q2	$3.63M	Buy	+9,137	New	+$3.68M	1.8%	11

Other funds holding DTIL

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Hamilton Lane Advisors's DTIL Position: Q1 2024 in Review

Hamilton Lane Advisors sold out of Precision BioSciences (DTIL) in Q1 2024, closing a stake of 2,637 shares — an estimated $28.9K sold.

Hamilton Lane Advisors first reported a position in DTIL in Q2 2019 and held it in 19 quarters. The position peaked at $3.63M in Q2 2019. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

Hamilton Lane Advisors reported no remaining Precision BioSciences position as of Q1 2024 after selling out during the quarter.
Hamilton Lane Advisors sold 2,637 Precision BioSciences shares in Q1 2024, an estimated $28.9K.
Hamilton Lane Advisors first reported a position in Precision BioSciences in Q2 2019 and held it in 19 quarters.
Hamilton Lane Advisors's Precision BioSciences position peaked at $3.63M in Q2 2019.
43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on Hamilton Lane Advisors's 13F filing for Q1 2024, filed 1 May 2024.